Panel Discussion: Making Prescription Drugs Accessible and Affordable
AMA PRA Category 1 CreditsTM are available! Click View More below for additional information.
this item can only be purchased by current members.
Would you like to...
This panel discussion will provide an overview of the challenges that prescription drug costs have brought to patients and families in Minnesota and engage the audience in a discussion of what policy changes are needed to ensure prescription drugs are both accessible and affordable.
Speaker: Sue Abderholden, MPH, Executive Director, NAMI Minnesota; Stephen W. Schondelmeyer, PharmD, PhD, FAPhA, Director, PRIME Institute, University of Minnesota; Nicole Smith-Holt, Patient Advocate
The faculty have reported that they has no actual or potential conflicts of interest in relation to this activity. The MMA staff and other planning committee members who were involved in the development and implementation of this activity have no actual or potential conflicts of interest in relation to this activity. No commercial support was received for the development or implementation of this activity.
To receive CME credit for this activity, complete and submit the online evaluation form. Upon successful completion of the evaluation, you will be emailed a certificate of completion within 2 weeks. You may contact the accredited provider with questions regarding this program at email@example.com. Participants must complete all necessary activity components by the above ‘valid through’ date to be eligible to claim CME credit.
The Minnesota Medical Association (MMA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The Minnesota Medical Association designates this enduring activity for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.